Organicell Regenerative Medicine, Inc. (OCEL) financial statements (2022 and earlier)

Company profile

Business Address 4045 SHERIDAN AVENUE
MIAMI, FL 33140
State of Incorp. NV
Fiscal Year End October 31
SIC 379 - Miscellaneous Transportation Equipment (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2022
TTM
10/31/2021
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments150109591133434026
Cash and cash equivalents150109591133434026
Receivables1141042926481151
Inventory, net of allowances, customer advances and progress billings15623514778 12010
Inventory15623514778 12010
Prepaid expense1277079121157 
Total current assets:54851784635810628137
Noncurrent Assets
Operating lease, right-of-use asset  105 
Property, plant and equipment1,2541,11336526365328
Other undisclosed noncurrent assets2773021855425
Total noncurrent assets:1,5311,416488268119633
TOTAL ASSETS:2,0791,9331,33462611737770
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,9571,873766552477592249
Accrued liabilities1,7301,5421,1568533282,184378
Other undisclosed accounts payable and accrued liabilities227331(391)(300)149(1,592)(129)
Debt10814023343238060100
Deferred rent credit     10
Due to related parties221221221    
Disposal group, including discontinued operation126126126126126126126
Other undisclosed current liabilities2,5371,7661,1949253493,093 
Total current liabilities:4,9494,1262,5402,0361,3323,881475
Noncurrent Liabilities
Long-term debt and lease obligation, including:309332186153   
Long-term debt, excluding current maturities309332     
Finance lease, liability  119 
Operating lease, liability  67 
Other undisclosed long-term debt and lease obligation   153   
Other undisclosed noncurrent liabilities108140(67)    
Total noncurrent liabilities:418472186153   
Other undisclosed liabilities      378
Total liabilities:5,3674,5992,7262,1891,3323,881853
Stockholders' equity
Stockholders' equity attributable to parent, including:(3,287)(2,666)(1,392)(1,563)(1,258)(3,557)(783)
Common stock1,1491,132940503436111104
Additional paid in capital38,88237,82726,53614,22012,8547,4171,226
Accumulated deficit(43,318)(41,625)(28,868)(16,285)(14,548)(11,086)(2,114)
Other undisclosed stockholders' equity attributable to parent    (0)  
Stockholders' equity attributable to noncontrolling interest    4353 
Total stockholders' equity:(3,287)(2,666)(1,392)(1,563)(1,215)(3,504)(783)
TOTAL LIABILITIES AND EQUITY:2,0791,9331,33462611737770

Income statement (P&L) ($ in thousands)

1/31/2022
TTM
10/31/2021
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
Revenues5,8285,5973,0561,702965570185
Gain on disposition of assets for financial service operations    821
Cost of revenue(529)(548)(399)(301)(209)(161)(94)
Cost of goods and services sold      (94)
Gross profit:5,2995,0502,6571,40175540990
Operating expenses(11,520)(17,794)(15,095)(3,178)(4,245)(9,051)(1,134)
Operating loss:(6,220)(12,744)(12,438)(1,776)(3,490)(8,642)(1,043)
Nonoperating income
(Other Nonoperating income)
4253385219 
Interest and debt expense(66) (178)(47)(228)(576)13
Other undisclosed income from continuing operations before equity method investments, income taxes32      
Loss from continuing operations before equity method investments, income taxes:(6,250)(12,719)(12,583)(1,738)(3,697)(9,208)(1,031)
Other undisclosed income (loss) from continuing operations before income taxes(50)(38)0 266  
Loss from continuing operations before income taxes:(6,300)(12,757)(12,583)(1,738)(3,431)(9,208)(1,031)
Income tax expense (benefit) 3,2153,168205(1,076)  
Other undisclosed income from continuing operations3,215      
Loss from continuing operations:(3,085)(9,541)(9,415)(1,534)(4,507)(9,208)(1,031)
Income from discontinued operations      197
Loss before gain (loss) on sale of properties:(3,085)(9,541)(9,415)(1,534)(4,507)(9,208)(833)
Other undisclosed net income (loss)(3,215)(3,215)(3,168)(205)1,07696 
Net loss:(6,300)(12,757)(12,583)(1,738)(3,431)(9,113)(833)
Net income (loss) attributable to noncontrolling interest   1(31)140 
Other undisclosed net loss attributable to parent      (420)
Net loss available to common stockholders, diluted:(6,300)(12,757)(12,583)(1,737)(3,462)(8,972)(1,253)

Comprehensive Income ($ in thousands)

1/31/2022
TTM
10/31/2021
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
Net loss:(6,300)(12,757)(12,583)(1,738)(3,431)(9,113)(833)
Other comprehensive loss      (1,253)
Comprehensive loss:(6,300)(12,757)(12,583)(1,738)(3,431)(9,113)(2,087)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest   1(31)140 
Comprehensive loss, net of tax, attributable to parent:(6,300)(12,757)(12,583)(1,737)(3,462)(8,972)(2,087)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: